Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : GLX-100 is a novel biopolymer, which has been designed to closely replicate the natural protective barrier layer and relieve the symptoms of Interstitial Cystitis/Bladder Pain Syndrome and Phase I results anticipated in 2024.
Brand Name : GLX-100
Molecule Type : Large molecule
Upfront Cash : Not Applicable
October 24, 2023
LOOKING FOR A SUPPLIER?
Reset All
